Bridget Ross

BRIDGET ROSS has a long and distinguished career with Johnson & Johnson and is currently the worldwide president of Acclarent, Inc., a medical device company based in Menlo Park, C.A., that was established in 2004. In 2009, Ross was appointed to the role of worldwide president of Ethicon Women’s Health & Urology and member of the Ethicon Franchise Global Management board. In this capacity, she developed innovative strategies to accelerate growth across the core business platforms. Prior to joining ETHICON, INC., she was vice president, commercial development, analytics and operations for the Johnson & Johnson North America pharmaceuticals business where she led new business and new product development, commercial analytics and operations and was a member of the North American Leadership Team. Ross began her Johnson & Johnson career in her home country of Canada in 1988 as a sales representative for what was then Janssen Pharmaceutica, Inc. She held a series of sales and marketing positions with increasing responsibility that ultimately led to the role of business unit director, Janssen-Ortho, Inc. in 1999. Ross earned a bachelor of commerce degree from The University of Alberta. @jnjnews

Subscribe to our eNewsletter